Amylyx Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
4.58
-0.29
(-5.95%)
Volume:
2,093,472
52 week range:
1.58 - 7.27
Market Cap:
408.266M
Company Description:
Amylyx Pharmaceuticals, Inc. develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product candidature includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid.